GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indraprastha Medical Corp Ltd (NSE:INDRAMEDCO) » Definitions » Operating Income

Indraprastha Medical (NSE:INDRAMEDCO) Operating Income : ₹1,392 Mil (TTM As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Indraprastha Medical Operating Income?

Indraprastha Medical's Operating Income for the three months ended in Dec. 2023 was ₹373 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,392 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Indraprastha Medical's Operating Income for the three months ended in Dec. 2023 was ₹373 Mil. Indraprastha Medical's Revenue for the three months ended in Dec. 2023 was ₹3,065 Mil. Therefore, Indraprastha Medical's Operating Margin % for the quarter that ended in Dec. 2023 was 12.16%.

Good Sign:

Indraprastha Medical Corp Ltd operating margin is expanding. Margin expansion is usually a good sign.

Indraprastha Medical's 5-Year average Growth Rate for Operating Margin % was 6.60% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Indraprastha Medical's annualized ROC % for the quarter that ended in Dec. 2023 was 25.10%. Indraprastha Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 53.37%.


Indraprastha Medical Operating Income Historical Data

The historical data trend for Indraprastha Medical's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indraprastha Medical Operating Income Chart

Indraprastha Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 524.49 544.36 76.60 851.30 1,123.00

Indraprastha Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 272.00 241.50 374.50 403.30 372.70

Indraprastha Medical Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indraprastha Medical  (NSE:INDRAMEDCO) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Indraprastha Medical's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=1490.8 * ( 1 - 27.61% )/( (4299.9 + 0)/ 1 )
=1079.19012/4299.9
=25.10 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Indraprastha Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1661.6/( ( (3113.5 + max(-1166.4, 0)) + (0 + max(0, 0)) )/ 1 )
=1661.6/( ( 3113.5 + 0 )/ 1 )
=1661.6/3113.5
=53.37 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(683.8 + 79.6 + 124.5) - (1421.1 + 0 + 633.2)
=-1166.4

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Indraprastha Medical's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=372.7/3064.6
=12.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Indraprastha Medical Operating Income Related Terms

Thank you for viewing the detailed overview of Indraprastha Medical's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Indraprastha Medical (NSE:INDRAMEDCO) Business Description

Traded in Other Exchanges
Address
Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.

Indraprastha Medical (NSE:INDRAMEDCO) Headlines

No Headlines